BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27054442)

  • 1. Gut microbiome and lipid metabolism: from associations to mechanisms.
    Wang Z; Koonen D; Hofker M; Fu J
    Curr Opin Lipidol; 2016 Jun; 27(3):216-24. PubMed ID: 27054442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota and HDL metabolism.
    Nakaya K; Ikewaki K
    Curr Opin Lipidol; 2018 Feb; 29(1):18-23. PubMed ID: 29135690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids.
    Fu J; Bonder MJ; Cenit MC; Tigchelaar EF; Maatman A; Dekens JA; Brandsma E; Marczynska J; Imhann F; Weersma RK; Franke L; Poon TW; Xavier RJ; Gevers D; Hofker MH; Wijmenga C; Zhernakova A
    Circ Res; 2015 Oct; 117(9):817-24. PubMed ID: 26358192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
    Brunkwall L; Orho-Melander M
    Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Nutrition and the Microbiome, Part I: Current State of the Science.
    Mills S; Stanton C; Lane JA; Smith GJ; Ross RP
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 31022973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gut microbiota in atherosclerosis.
    Jonsson AL; Bäckhed F
    Nat Rev Cardiol; 2017 Feb; 14(2):79-87. PubMed ID: 27905479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of gut microbiota on drug metabolism and toxicity.
    Li H; He J; Jia W
    Expert Opin Drug Metab Toxicol; 2016; 12(1):31-40. PubMed ID: 26569070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the contribution of gut microbiome to the variance of porcine serum glucose and lipid concentration.
    Huang X; Fang S; Yang H; Gao J; He M; Ke S; Zhao Y; Chen C; Huang L
    Sci Rep; 2017 Nov; 7(1):14928. PubMed ID: 29097803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving microbiota research toward establishing causal associations that represent viable targets for effective public health interventions.
    Mai V; Prosperi M; Yaghjyan L
    Ann Epidemiol; 2016 May; 26(5):306-10. PubMed ID: 27133768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes.
    Taguer M; Maurice CF
    Clin Pharmacol Ther; 2016 Jun; 99(6):588-99. PubMed ID: 26950037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents.
    Ejtahed HS; Soroush AR; Angoorani P; Larijani B; Hasani-Ranjbar S
    Horm Metab Res; 2016 Jun; 48(6):349-58. PubMed ID: 27203411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Core Gut Microbiome of the American Cockroach, Periplaneta americana, Is Stable and Resilient to Dietary Shifts.
    Tinker KA; Ottesen EA
    Appl Environ Microbiol; 2016 Nov; 82(22):6603-6610. PubMed ID: 27590811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking Microbiota to Human Diseases: A Systems Biology Perspective.
    Wu H; Tremaroli V; Bäckhed F
    Trends Endocrinol Metab; 2015 Dec; 26(12):758-770. PubMed ID: 26555600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding role of gut microbiota in lipid metabolism.
    Ghazalpour A; Cespedes I; Bennett BJ; Allayee H
    Curr Opin Lipidol; 2016 Apr; 27(2):141-7. PubMed ID: 26855231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and microbiome influence on lipid metabolism and dyslipidemia.
    Matey-Hernandez ML; Williams FMK; Potter T; Valdes AM; Spector TD; Menni C
    Physiol Genomics; 2018 Feb; 50(2):117-126. PubMed ID: 29341867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism.
    Enright EF; Griffin BT; Gahan CGM; Joyce SA
    Pharmacol Res; 2018 Jul; 133():170-186. PubMed ID: 29660405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-resolved metaproteomic characterization of preterm infant gut microbiota development reveals species-specific metabolic shifts and variabilities during early life.
    Xiong W; Brown CT; Morowitz MJ; Banfield JF; Hettich RL
    Microbiome; 2017 Jul; 5(1):72. PubMed ID: 28693612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From next-generation sequencing to systematic modeling of the gut microbiome.
    Ji B; Nielsen J
    Front Genet; 2015; 6():219. PubMed ID: 26157455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota and the Gut-Brain Axis: New Insights in the Pathophysiology of Metabolic Syndrome.
    de Clercq NC; Frissen MN; Groen AK; Nieuwdorp M
    Psychosom Med; 2017 Oct; 79(8):874-879. PubMed ID: 28557822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models. Part II: Results.
    Hughes RL; Kable ME; Marco M; Keim NL
    Adv Nutr; 2019 Nov; 10(6):979-998. PubMed ID: 31225587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.